Active	Status	Sponsor type	Region	Phase	Filter
4 Active 5 Inactive 9 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

4 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Bonetti, Andrea
GALAXIES LUNG-201, NCT05565378 / 2021-005115-32: A Platform Study of Novel Immunotherapy Combinations in Participants With Previously Untreated, Advanced/Metastatic Non-Small-Cell Lung Cancer	Recruiting	2	340	Europe, Japan, US, RoW	Pembrolizumab, Dostarlimab, GSK4057190, Belrestotug, EOS884448, GSK4428859A, Nelistotug, GSK6097608	GlaxoSmithKline, iTeos Therapeutics	Lung Cancer, Non-Small Cell	10/25	10/28
NCT04810182: Regorafenib in Patients With Relapsed Glioblastoma. IOV-GB-1-2020 REGOMA-OSS	Completed	N/A	192	Europe	Regorafenib 40 MG Oral Tablet [STIVARGA]	Istituto Oncologico Veneto IRCCS	Glioblastoma Multiforme	12/23	12/23
SPECTA, NCT02834884: Screening Cancer Patients for Efficient Clinical Trial Access	Recruiting	N/A	4975	Europe, RoW	RP-1828 IMMUcan, RP-1759 AYA/TYA, RP-1843 Arcagen, RP-1920 BioRadon	European Organisation for Research and Treatment of Cancer - EORTC	All Tumor Types	03/26	03/26
PRIMALung, NCT04790253: PRophylactic Cerebral Irradiation or Active MAgnetic Resonance Imaging Surveillance in Small-cell Lung Cancer Patients ( Study)	Recruiting	N/A	600	Europe	Prophylactic cranial irradiation	European Organisation for Research and Treatment of Cancer - EORTC, UNICANCER	Limited Stage Small Cell Lung Cancer, Extensive-stage Small-cell Lung Cancer	04/28	04/28